title: [Retroperitoneal lymphadenectomy and survival of patients treated for an advanced ovarian cancer: the CARACO trial].
abstract: The standard management for advanced-stage epithelial ovarian cancer is optimum cytoreductive surgery followed by platinum based chemotherapy. However, retroperitoneal lymph node resection remains controversial. The multiple directions of the lymph drainage pathway in ovarian cancer have been recognized. The incidence and pattern of lymph node involvement depends on the extent of the disease and the histological type. Several published cohorts suggest the survival benefit of pelvic and para-aortic lymphadenectomy. A recent large randomized trial have demonstrated the potential benefit for surgical removal of bulky lymph nodes in term of progression-free survival but failed to show any overall survival benefit because of a critical methodology. Further randomised trials are needed to balance risks and benefits of systematic lymphadenectomy in advanced-stage disease. CARACO is a French ongoing trial, built to bring a reply to this important question. A huge effort for inclusion of the patients, and involving new teams, are mandatory.
authors.affiliation: Département de chirurgie oncologique, centre René-Gauducheau-ICO, boulevard Jean-Monod, Nantes-Saint-Herblain, France. jm-classe@nantes.fnclcc.fr
authors.forename: J-M
authors.initials: JM
authors.lastname: Classe
authors.forename: E
authors.initials: E
authors.lastname: Cerato
authors.forename: C
authors.initials: C
authors.lastname: Boursier
authors.forename: J
authors.initials: J
authors.lastname: Dauplat
authors.forename: C
authors.initials: C
authors.lastname: Pomel
authors.forename: R
authors.initials: R
authors.lastname: Villet
authors.forename: J
authors.initials: J
authors.lastname: Cuisenier
authors.forename: G
authors.initials: G
authors.lastname: Lorimier
authors.forename: J-F
authors.initials: JF
authors.lastname: Rodier
authors.forename: P
authors.initials: P
authors.lastname: Mathevet
authors.forename: G
authors.initials: G
authors.lastname: Houvenaeghel
authors.forename: J
authors.initials: J
authors.lastname: Leveque
authors.forename: F
authors.initials: F
authors.lastname: Lécuru
mesh_terms: D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008207:Lymphatic Metastasis / Q000473:pathology; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality* / Q000473:pathology / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic; D012187:Retroperitoneal Space; D015996:Survival Rate